An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …
[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems
VS Madamsetty, R Mohammadinejad… - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
[HTML][HTML] COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment–A narrative review
CA Pfortmueller, T Spinetti, RD Urman… - Best Practice & …, 2021 - Elsevier
Abstract (163 words) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …
[HTML][HTML] NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel
N Krinsky, S Sizikov, S Nissim, A Dror, A Sas… - Journal of Thrombosis …, 2023 - Elsevier
Background COVID-19 severity and its late complications continue to be poorly understood.
Neutrophil extracellular traps (NETs) form in acute COVID-19, likely contributing to morbidity …
Neutrophil extracellular traps (NETs) form in acute COVID-19, likely contributing to morbidity …
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic
Abstract A Lancet Commission for COVID-19 task force is shaping recommendations to
achieve vaccine and therapeutics access, justice, and equity. This includes ensuring safety …
achieve vaccine and therapeutics access, justice, and equity. This includes ensuring safety …
Nanomaterials for photocatalytic degradations of analgesic, mucolytic and anti-biotic/viral/inflammatory drugs widely used in controlling SARS-CoV-2
M Ebrahimi, O Akhavan - Catalysts, 2022 - mdpi.com
The COVID-19 pandemic has been transformed into one of the main worldwide challenges,
in recent years. For controlling symptoms that are caused by this disease (eg, chills or fever …
in recent years. For controlling symptoms that are caused by this disease (eg, chills or fever …
COVID-19-associated candidiasis: possible patho-mechanism, predisposing factors, and prevention strategies
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …
SARS‐CoV‐2 and its variants of concern including Omicron: a never ending pandemic
RK Mohapatra, S Kuppili… - Chemical Biology & …, 2022 - Wiley Online Library
The ongoing COVID‐19 pandemic caused by SARS‐CoV‐2 is associated with high
morbidity and mortality. This zoonotic virus has emerged in Wuhan of China in December …
morbidity and mortality. This zoonotic virus has emerged in Wuhan of China in December …